Walgreens agrees to pay nearly $230 million for San Francisco opioid settlement
The pharmacy giant will pay the city over the next 14 years
Telsey Advisory Group CEO Dana Telsey and Tigress Financial Partners CIO Ivan Feinseth discuss whether inflation is finally forcing consumers to pull back on spending on 'The Claman Countdown.'
Walgreens Boots Alliance Inc. has agreed to pay San Francisco nearly $230 million to settle a lawsuit for its role in the city's opioid crisis, San Francisco City Attorney David Chiu said in a press release Wednesday.
The pharmacy giant will pay $229.6 million to the city over the next 14 years, Chiu said in a press release, with the majority of this payment coming in the first eight years.
NEW YORK TIMES DRAGGED FOR ELIZABETH HOLMES PROFILE: ‘VERY EMBARRASSING’
The settlement came nine months after U.S. District Judge Charles Breyer in San Francisco said the drugstore chain could be held liable for having "substantially contributed" to an opioid epidemic that caused "widespread harm" in the city and constituted a public nuisance.
Breyer faulted Walgreens for its "15-year failure" to properly scrutinize opioid prescriptions and flag possible misuse of the sometimes highly addictive drugs.
A sign for Walgreens is displayed outside its store in Washington, DC, on November 2, 2022. CVS Health said they had agreed to pay approximately $5 billion over 10 years to "resolve all opioid lawsuits and claims" against them by states and cities. (BRENDAN SMIALOWSKI/AFP via Getty Images / Getty Images)
At a press conference, Chiu called Walgreens' settlement the largest awarded to a local government in years of opioid litigation nationwide.
"Opioids have wreaked havoc across our nation leading to immense suffering and untold damage," said Chiu. "Cities like San Francisco have shouldered much of the burden of the opioid epidemic."
"Cities like San Francisco have shouldered much of the burden of the opioid epidemic."
He said Walgreens' actions "made the opioid epidemic in San Francisco worse than it otherwise would have been," and that there is "no amount of money that will bring back the lives we have lost."
In a statement, Walgreens said it "disputes liability" and did not admit fault, but that settling allows it to focus on patients, customers and communities. "Our thoughts are with those impacted by this tragic crisis," it added.
Attention Walgreens no longer carries Promethazine with Codeine sign on front entrance of pharmacy, often used in illegal purple drank as a recreational drug, Queens, New York. (Lindsey Nicholson/UCG/Universal Images Group via Getty Images / Getty Images)
In his ruling in Aug. 2022, Breyer found that Walgreens suffered from a profit-driven "fill, fill, fill" culture in dispensing opioids.
Breyer ruled that Walgreens' San Francisco pharmacies received more than 1.2 million opioid prescriptions with "red flags" from 2006 to 2020, yet only performed due diligence on less than 5% before dispensing them to residents.
NEW DRUGS ARE COMING TO MARKET AT SKY-HIGH PRICES
Walgreens' settlement averts a trial to determine damages.
San Francisco had estimated it might cost $8.1 billion to abate the opioid crisis, and that Walgreens was legally liable for the entire amount.
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| WBA | WALGREENS BOOTS ALLIANCE INC. | 8.48 | -0.33 | -3.75% |
Last May, Walgreens reached a $683 million opioid settlement with Florida, paying more than three-quarters of the $878 million that four other companies, including rival CVS Health Corp, agreed to pay in similar, earlier settlements.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
More than 600,000 people have died from drug overdoses in the United States from 1999 to 2021, including more than 107,000 in 2021 alone, according to the U.S. Centers for Disease Control and Prevention.
Reuters contributed to this report.